UTMD 10-Q: SEC filing

Utah Medical Products Inc

Filed with the SEC on Nov 13, 2026 · accession 0001096906-26-001742

UTMD filed a 10-Q (quarterly report) with the SEC on Nov 13, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -2.3% by the first close after the filing.

Summary of the filing

Utah Medical Products Inc filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures.

For details, click here →How to read a 10-Q →

Key details

FilerUtah Medical Products Inc

How UTMD stock reacted

Close before

$73.63

Nov 12, 2026

First close after

-2.25%

$71.97

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for UTMD, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for UTMD?

Click here

Frequently asked questions

What did UTMD file with the SEC on Nov 13, 2026?

UTMD filed a 10-Q (SEC filing). Utah Medical Products Inc filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did UTMD stock react to this filing?

UTMD closed at $73.63 before the filing and $71.97 on Nov 13, 2026 (-2.25%).

Other UTMD SEC filings

Get alerts when UTMD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

UTMD overview UTMD analysis UTMD news Latest SEC filings